Abstract
The phenotype HNPP (hereditary neuropathy with liability to pressure palsies) is caused by heterozygous deletion of the PMP22 gene. HNPP is clinically characterized by asymmetric focal sensory loss and muscle weakness. Reports of HNPP have been rare.
In this article, we report the case of an asymptomatic woman with the HNPP mutation. After undergoing total knee arthroplasty, she developed a footdrop with prolonged recovery. We concluded (a) that the HNPP mutation may carry a high risk for certain surgical procedures not expected to cause neurologic deficits in normal patients and (b) that humans with the HNPP mutation can be asymptomatic. Lack of symptoms can contribute to underrecognition of the disease.
PMP22 is a tetra-span membrane protein primarily expressed in myelinating Schwann cells. Heterozygous deletion of the PMP22 gene (1 copy) causes HNPP (hereditary neuropathy with liability to pressure palsies).1 Interestingly, a reciprocal genetic disorder with 3 copies of human PMP22 causes the most common inherited neuropathy, Charcot-Marie-Tooth disease type 1A (CMT1A).2,3 As the reciprocal mutations occur at initiation of gestation, it is expected that HNPP and CMT1A have a similar prevalence. However, studies have shown HNPP prevalence of 2 to 5 cases per 100,000, far below the CMT1A prevalence of 1:5000.4 This finding prompted speculation that many patients with HNPP may be undiagnosed because of the subtlety of the phenotypes.5
Patients with HNPP typically present with focal sensory loss and muscle weakness related to mechanical stress–induced failure of action potential propagation.6,7 In this article, we report the case of an asymptomatic woman with the HNPP mutation. Her focal neurologic deficits occurred only after total knee arthroplasty (TKA), which in healthy patients is not expected to induce focal sensory and motor symptoms. The patient provided written informed consent for print and electronic publication of this case report.
Case Report
The patient, a healthy 57-year-old woman, had a normal developmental history. For decades, she had practiced ballet without any physical difficulties. She underwent left TKA and woke up with a footdrop on the left side. The left foot was less sensitive to temperature. Ankle strength returned 2 months later. There was no family history of HNPP.
The patient was examined by a local neurologist, who found steppage gait, weak ankle dorsiflexion (4 on Medical Research Council scale), and diminished touch on the lateral aspect of the left leg. Deep tendon reflexes were present in the arms but not the legs.
A nerve conduction study (NCS) performed after the footdrop revealed prolonged distal latency and decreased amplitude in the left peroneal and tibial nerves. The left sural nerve was normal. Needle electromyogram revealed denervation changes in the muscles innervated by the left peroneal nerve (Table). In addition, we also performed an NCS on the arm (Table), which was unaffected by the surgical procedure. This NCS revealed severely prolonged distal latency across the left wrist in the median nerve and focal slowing of conduction velocity of the ulnar nerve across the left elbow. These changes provide evidence of asymptomatic carpal tunnel syndrome and ulnar nerve entrapment, typical electrophysiologic abnormalities of HNPP.8
Table.
Motor Nerves | Sensory Nerves | |||||
---|---|---|---|---|---|---|
DL, ms | Amp, mV | CV, m/s | DL, ms | Amp, µV | CV, m/s | |
First Case | ||||||
Peroneal | 6.1 | 0.8 | N/A | — | — | — |
Sural Norm |
— ≤6.0 |
— ≥2.5 |
— | 3.8 ≤4.0 |
11.2 ≥5.0 |
42.9 ≥39.0 |
Tibial | 6.7 | 0.7 | N/A | — | — | — |
Median Norm |
13.1 ≤4.5 |
4.0 ≥4.0 |
44.8 ≥50.0 |
NR ≤4.0 |
— ≥20.0 |
— ≥50.0 |
Ulnar Norm |
3.9 ≤3.5 |
7.8 ≥6.0 |
32.8 ≥50.0 |
5.4 ≤3.5 |
14.4 ≥10.0 |
32.7 ≥50.0 |
Abbreviations: Amp, amplitude; CV, conduction velocity; DL, distal latency; norm, normative value; N/A, not applicable; NR, nonresponsive.
Abnormal values in bold.
As there was no explanation for the footdrop from the surgery, we had a DNA test performed (Athena Diagnostics). This test identified a heterozygous deletion of chromosome 17p12 containing the PMP22 gene, the HNPP mutation.
Discussion
This case had several important features. First, though the patient developed an electrophysiologic phenotype of HNPP, she was completely asymptomatic clinically and very athletic before her medical procedure. She would not have been diagnosed with HNPP if her clinical deficits had not been induced by TKA. Therefore, the prevalence of HNPP is likely underestimated. Second, for patients with the HNPP mutation, there may be serious neurologic consequences of certain medical procedures. The diagnosis of HNPP should be pursued if there is no explanation from the medical procedure per se. In addition, patients with a family history of HNPP should be carefully evaluated before any procedure that may put them at risk for severe peripheral nerve damage, and they should be counseled regarding the risks. It is important to determine the prevalence of HNPP among patients who develop footdrop after knee arthroplasty, as this information could potentially be used to revise ideas about the etiology of peripheral nerve complications of knee arthroplasty. We now describe possible revisions of these ideas.
Footdrop is a rare complication of TKA. Retrospective studies have found its incidence ranging from 0.3% to 1.3%.9–11 The investigators in those studies postulated 3 main causes for peroneal nerve palsy. First, traction may put pressure on the peroneal nerve during normalization of the mechanical axis of a valgus knee. Our patient did not have a valgus knee. Second, epidural hematoma by anesthetic procedure may compress the spinal roots. Our patient received general anesthesia during the procedure; epidural or spinal anesthesia was not used. Third, postoperative dressing may compress the nerve. Our patient did not develop any signs of constrictive dressing, such as inordinate pain, which can be relieved by removing the dressing, and swelling of the leg distal to the dressing. Therefore, her footdrop likely was not a complication of surgery.
This case demonstrates how a patient with undiagnosed HNPP can manifest the HNPP phenotype only after undergoing a particular surgical procedure. HNPP is unfamiliar to most orthopedic surgeons.
Acknowledgments
This research was in part supported by National Institute of Neurological Disorders and Stroke grant R01NS066927 to Dr. Li.
Footnotes
Authors’ Disclosure Statement: The authors report no actual or potential conflict of interest in relation to this article.
Contributor Information
Dr. Mark Kramer, Orthopedic Surgeon, Cohen & Kramer MD, PC, Bronxville, New York.
Dr. Amy Ly, Neurology Resident, Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tennessee.
Dr. Jun Li, Department of Neurology, Center for Human Genetics Research, Vanderbilt Brain Institute, Vanderbilt University School of Medicine, Nashville, Tennessee.
References
- 1.Chance PF, Alderson MK, Leppig KA, et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell. 1993;72(1):143–151. doi: 10.1016/0092-8674(93)90058-x. [DOI] [PubMed] [Google Scholar]
- 2.Lupski JR, de Oca-Luna RM, Slaugenhaupt S, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell. 1991;66(2):219–232. doi: 10.1016/0092-8674(91)90613-4. [DOI] [PubMed] [Google Scholar]
- 3.Raeymaekers P, Timmerman V, Nelis E, et al. Estimation of the size of the chromosome 17p11.2 duplication in Charcot-Marie-Tooth neuropathy type 1a (CMT1a). HMSN Collaborative Research Group. J Med Genet. 1992;29(1):5–11. doi: 10.1136/jmg.29.1.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Meretoja P, Silander K, Kalimo H, Aula P, Meretoja A, Savontaus ML. Epidemiology of hereditary neuropathy with liability to pressure palsies (HNPP) in south western Finland. Neuromuscul Disord. 1997;7(8):529–532. doi: 10.1016/s0960-8966(97)00100-4. [DOI] [PubMed] [Google Scholar]
- 5.Li J, Parker B, Martyn C, Natarajan C, Guo J. The PMP22 gene and its related diseases. Mol Neurobiol. 2013;47(2):673–698. doi: 10.1007/s12035-012-8370-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Bai Y, Zhang X, Katona I, et al. Conduction block in PMP22 deficiency. J Neurosci. 2010;30(2):600–608. doi: 10.1523/JNEUROSCI.4264-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Guo J, Wang L, Zhang Y, et al. Abnormal junctions and permeability of myelin in PMP22-deficient nerves. Ann Neurol. 2014;75(2):255–265. doi: 10.1002/ana.24086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Li J, Krajewski K, Shy ME, Lewis RA. Hereditary neuropathy with liability to pressure palsy: the electrophysiology fits the name. Neurology. 2002;58(12):1769–1773. doi: 10.1212/wnl.58.12.1769. [DOI] [PubMed] [Google Scholar]
- 9.Rose HA, Hood RW, Otis JC, Ranawat CS, Insall JN. Peroneal-nerve palsy following total knee arthroplasty. A review of the Hospital for Special Surgery experience. J Bone Joint Surg Am. 1982;64(3):347–351. [PubMed] [Google Scholar]
- 10.Schinsky MF, Macaulay W, Parks ML, Kiernan H, Nercessian OA. Nerve injury after primary total knee arthroplasty. J Arthroplasty. 2001;16(8):1048–1054. doi: 10.1054/arth.2001.26591. [DOI] [PubMed] [Google Scholar]
- 11.Nercessian OA, Ugwonali OF, Park S. Peroneal nerve palsy after total knee arthroplasty. J Arthroplasty. 2005;20(8):1068–1073. doi: 10.1016/j.arth.2005.02.010. [DOI] [PubMed] [Google Scholar]